[go: up one dir, main page]

AU2001239301A1 - Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression - Google Patents

Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression

Info

Publication number
AU2001239301A1
AU2001239301A1 AU2001239301A AU3930101A AU2001239301A1 AU 2001239301 A1 AU2001239301 A1 AU 2001239301A1 AU 2001239301 A AU2001239301 A AU 2001239301A AU 3930101 A AU3930101 A AU 3930101A AU 2001239301 A1 AU2001239301 A1 AU 2001239301A1
Authority
AU
Australia
Prior art keywords
ectoin
prophylaxis
treatment
derivatives
induced immunosuppression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239301A
Inventor
Joachim Bunger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2001239301A1 publication Critical patent/AU2001239301A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/001—Preparations for care of the lips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001239301A 2000-03-24 2001-03-15 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression Abandoned AU2001239301A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10014631A DE10014631A1 (en) 2000-03-24 2000-03-24 Treating or preventing UV-induced immunosuppression, using ectoine or its derivatives, is useful in topical care or make-up cosmetic compositions for maintaining the barrier effect of the skin
DE10014631 2000-03-24
PCT/EP2001/002988 WO2001072287A2 (en) 2000-03-24 2001-03-15 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression

Publications (1)

Publication Number Publication Date
AU2001239301A1 true AU2001239301A1 (en) 2001-10-08

Family

ID=7636176

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239301A Abandoned AU2001239301A1 (en) 2000-03-24 2001-03-15 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression

Country Status (6)

Country Link
US (1) US20030198609A1 (en)
EP (1) EP1265613A2 (en)
JP (1) JP2003528132A (en)
AU (1) AU2001239301A1 (en)
DE (1) DE10014631A1 (en)
WO (1) WO2001072287A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1478327B1 (en) * 2002-02-22 2015-04-29 Meda AB Method of reducing and treating uvb-induced immunosuppression
DE10214257A1 (en) * 2002-03-28 2003-10-16 Merck Patent Gmbh Use of compatible solutes to inhibit the release of ceramides
DE10330768A1 (en) 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Use of osmolytes obtained from extremophilic bacteria for the preparation of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases, and an inhalation device containing osmolyte as an active ingredient
DE10337863A1 (en) * 2003-08-18 2005-03-17 Merck Patent Gmbh Use of chromene-4-one derivatives
US20050255072A1 (en) * 2004-01-20 2005-11-17 Jampani Hanuman B Two-phase compositions containing alcohol
JP4659764B2 (en) * 2004-12-27 2011-03-30 株式会社ポッカコーポレーション Manufacturing method of antioxidant material
US9040030B2 (en) * 2010-12-30 2015-05-26 L'oreal Mascara compositions containing an oil-dispersible micronized wax and a water-dispersible wax

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004128A2 (en) * 1992-08-26 1994-03-03 Beiersdorf Ag Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions
DE4342560A1 (en) * 1993-12-14 1995-06-22 Marbert Gmbh Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics
DE19933464A1 (en) * 1998-07-10 2000-01-13 Beiersdorf Ag Cosmetic or dermatological dispersions having radical scavenging and antioxidant activity, useful e.g. for preventing skin aging and inflammatory reactions
ES2228089T3 (en) * 1998-08-01 2005-04-01 Merck Patent Gmbh EMPLOYMENT OF ECTOINE OR ECTOINE DERIVATIVES IN COSMETIC FORMULATIONS.
DE19834816A1 (en) * 1998-08-01 2000-02-03 Merck Patent Gmbh Use of ectoin or ectoin derivatives in cosmetic formulations

Also Published As

Publication number Publication date
WO2001072287A2 (en) 2001-10-04
US20030198609A1 (en) 2003-10-23
WO2001072287B1 (en) 2002-06-06
DE10014631A1 (en) 2001-09-27
EP1265613A2 (en) 2002-12-18
WO2001072287A3 (en) 2002-03-28
JP2003528132A (en) 2003-09-24

Similar Documents

Publication Publication Date Title
PL369006A1 (en) Preparation for the prophylaxis of restenosis
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU2001271567A1 (en) Use of geldanamycin and related compounds for prophylaxis or treatment of fibrogenic disorders
AU3276802A (en) Background of the invention
AU2001272852A1 (en) Composition for the treatment of migraine
AU2000276362A1 (en) Composition for the treatment of diabetes
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2001248214A1 (en) Device for the introduction of medical items
AU5468801A (en) Use of ectoin or ectoin derivatives for protecting stress proteins in the skin
AU2001253165A1 (en) Use of fluorocarbons for the prevention of surgical adhesions
AU2001277534A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
AU4694999A (en) Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
PL361733A1 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
IL155360A0 (en) Processes for the isolation or purification of plavastatin and compositions containing plavastatin
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
AU2001239301A1 (en) Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression
WO2001093878A8 (en) Bismuth compounds for the treatment and prevention of mucositis
AU2001252132A1 (en) Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/ortreatment of anemias
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2002365621A1 (en) Composition for treating the surface of the skin
PT1698338E (en) S-methyl-dihydro-ziprasidone for the treatment of schizophrenia
AU2001286489A1 (en) Process for the purification of iosoctane and/or diisobutylene
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
AU2683500A (en) Compositions for the treatment of pain